Login / Signup

Oral lesions postinjection of the first administration of Pfizer-BioNTech SARS-CoV-2 (BNT162b2) vaccine.

Maddalena ManfrediGiulia GhidiniErminia RidoloSilvia Pizzi
Published in: Oral diseases (2021)
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • coronavirus disease